CV Sciences officers poised to settle shareholder derivative lawsuit
The hemp products company CV Sciences Inc. has had a rough go since attracting the attention of a short seller in 2018.
Stay updated with breaking news from Continued Examination. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The hemp products company CV Sciences Inc. has had a rough go since attracting the attention of a short seller in 2018.
On October 3, 2022, the majority of the amendments introduced by the Rules Amending the Patent Rules on June 2, 2022, came into force and effect. The amendments aim to streamline the...
To accelerate innovation in the health and medical fields, the USPTO published a Federal Register Notice announcing a fifth extension of its Cancer Immunotherapy Pilot Program.
Despite its name, a "final" office action from the United States Patent and Trademark Office (USPTO) does not mean your trademark application has been rejected. Instead...
The US Patent & Trademark Office (PTO) is seeking public input and guidance on proposed initiatives directed at bolstering the robustness and reliability of patents. The request for...